LY3108743

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3108743, covering 2014-07-15 to 2014-07-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3108743 in Healthy Participants and Participants With Type 2 Diabetes [Phase 1]